REVVITY INC. 16/26REVVITY INC. 16/26REVVITY INC. 16/26

REVVITY INC. 16/26

No trades
See on Supercharts

XS140578061 analysis



Key facts


Issue date
Jul 19, 2016
Maturity date
Jul 19, 2026
Outstanding amount
‪500.00 M‬EUR
Face value
1,000.00EUR
Minimum denomination
100,000.00EUR
Coupon
1.88% (Fixed)
Yield to maturity
2.49%
Revvity, Inc. provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, and informatics. The firm operates through the following segments: Life Sciences and Diagnostics. The Life Sciences segment delivers innovative solutions to optimize workflows, boost productivity, and accelerate drug discovery and development. The Diagnostics segment provides instruments, reagents, assay platforms, and software to healthcare and research professionals, with a focus on reproductive health, immunodiagnostics, emerging market diagnostics, and applied genomics to enhance patient outcomes. Revvity was founded on April 19, 1937 and is headquartered in Waltham, MA.
Go deeper with bond data
Access the most important data for bonds including coupon rates, issue ratings, redemption data and more.